Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Curon Medical Inc. (NasdaqNM:CURN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug 16Price hit new 52-week low ($1.93)
Location
735 Palomar Avenue
Sunnyville, CA 94085
Phone: (408) 733-9910
Fax: (408) 522-8699
Email: gjones@curonmedical.com
Employees (last reported count): 73
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 55%
·Over the last 6 months:
 · one insider sell; 5,000  shares
·Institutional: 35% (79% of float)
(32 institutions)
·Net Inst. Selling: 386.0K shares (+5.90%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Curon Medical Inc. develops, manufactures and markets products for the treatment of gastrointestinal disorders. Its products consist of radio frequency generators and single-use disposable devices. The Company's first product, the Stretta System, is indicated for gastroesophageal reflux disease (GERD). Unlike medication, which temporarily suppresses GERD symptoms, the Stretta System is designed to apply radio frequency energy to treat the causes of GERD. The Company's second product, the Secca System, is currently under development for the treatment of fecal incontinence. Curon has developed a suite of products incorporating design features for use in the Stretta and Secca procedures. These products consist of a disposable catheter and a disposable hand piece for delivery of controlled radio frequency energy to tissue and a radio frequency generator, known as the Curon Control Module. All of the Company's products utilize proprietary software to interface with its Curon Control Module.
More from Market Guide: Expanded Business Description

Financial Summary
Curon Medical, Inc. develops, manufactures and markets proprietary products for the treatment of gastrointestinal disorders. For the six months ended 6/30/01, revenues totalled $1.8 million, up from $170 thousand. Net loss decreased 10% to $7.3 million. Revenues reflect the begining of commercial shipments of the Stretta System in June 2000. Lower net loss reflects decreased research and development expenses and higher interest income.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Michael Berman, 43
Chairman
--  --  
John Morgan, 41
Pres, CEO, Director
$250K$130K
Alistair McLaren, 60
CFO, VP of Fin. and Admin.
183K35K
Jim Goode
VP of Sales
--  --  
Carol Chludzinski, 46
VP of Marketing
165K24K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CURNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 16-Aug-2001
$1.93 
Recent Price$2.39 
52-Week High
on 6-Nov-2000
$14.75 
Daily Volume (3-month avg)44.0K
Daily Volume (10-day avg)8,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
26-Week Change-49.7%
26-Week Change
relative to S&P500
-45.2%
Share-Related Items
Market Capitalization$46.7M
Shares Outstanding19.5M
Float8.80M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.49 
Earnings (ttm)-$1.94 
Earnings (mrq)-$0.23 
Sales (ttm)$0.18 
Cash (mrq)$2.17 
Valuation Ratios
Price/Book (mrq)0.96 
Price/EarningsN/A 
Price/Sales (ttm)13.04 
Income Statements
Sales (ttm)$2.77M
EBITDA (ttm)-$10.5M
Income available to common (ttm)-$16.6M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-35.41%
Return on Equity (ttm)-40.71%
Financial Strength
Current Ratio (mrq)37.57 
Debt/Equity (mrq)0 
Total Cash (mrq)$42.4M
Short Interest
As of 8-Aug-2001
Shares Short5,000 
Percent of Float0.1%
Shares Short
(Prior Month)
10.0K
Short Ratio0.12 
Daily Volume41.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.